GlassScriptPhysician profile
Randall Gordon Stern
NPI 1962512319
$69,721.79
in general payments reported to CMS, 2019-2025
22 companies · $449 in 2025
The $449 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $2,978 · 2021: $7,160 · 2022: $3,331 · 2023: $900 · 2024: $271 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $65,743.98 | 2019-2023 | Xarelto |
| W. L. Gore & Associates, INC. | $1,380.46 | 2020-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Shockwave Medical, INC | $608.33 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $423.55 | 2019-2021 | |
| Medtronic Vascular, INC. | $302.58 | 2019-2020 | |
| Urgo Medical North America, LLC | $291.52 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Penumbra, INC. | $166.18 | 2025 | Ruby Coil |
| Humacyte Global, INC. | $145.32 | 2025 | Symvess |
| Polynovo North America LLC | $133.06 | 2023 | |
| Bolton Medical INC | $126.26 | 2021-2023 | Treo Abdominal Stent-Graft System |
| Cook Medical LLC | $72.79 | 2021-2023 | Zenith Alpha |
| Smith+Nephew, INC. | $53.92 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $45.07 | 2021-2022 | |
| Cardiovascular Systems INC. | $41.01 | 2021-2022 | |
| Organogenesis INC. | $40.05 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $34.09 | 2023 | Xarelto |
| Lemaitre Vascular, INC. | $23.80 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.93 | 2021 | |
| Cordis US Corp. | $19.90 | 2022 | |
| Kci USA, INC. | $17.83 | 2022 | |
| Boston Scientific Corporation | $16.97 | 2023 | |
| Integra Lifesciences Corporation | $14.19 | 2025 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.